INTRODUCTION
In our previous reports, we have shown that mice inoculated with heat-inactivated BCG acquired a high non-specific resistance to virus infection, and that this acquired resistance was due mainly to enhanced interferon production in the BCG-inoculated mice (Suenaga et al., 1978; Sakuma et al., 1983) . We have also shown that N-acetyl-muramyl-L-alanyl-D-isoglutamine (MDP), which is the minimal active portion of the peptidoglycan of the bacterial cell wall for adjuvant activity (Ellouz et al., 1974; Adam et al., 1976; Kusumoto et al., 1976; Tanaka et al., 1979) , has no enhancing activity on resistance to virus infection (Sakuma et al., 1984) , though MDP has been reported to potentiate non-specific resistance to bacterial and mycotic infection (Chedid et al., 1977; Cummings et al., 1980; Yamamoto et al., 1980; Matsumoto et al., 1981) .
Trehalose-6,6'-dimycolate (cord factor; TDM) is a glycolipid component of the cell wall of Mycobacterium, Corynebacterium and Nocardia, and has haptenic activity (Ohara et al., 1957) , granulomagenic activity (Bekierkunst, 1968; Bekierkunst et al., 1969; Barksdale & Kim, 1977; Yamamoto et al., 1980) , adjuvant activity (Bekierkunst et al., 197t ; Granger et aL, 1976) and anti-tumour activity (Goren & Brennan, 1979) . Bekierkunst (1968) and Yarkoni & Bekierkunst (1976) have reported that TDM enhanced non-specific resistance to bacterial infections, although the mechanism remains to be defined. The purpose of the present study was to determine whether TDM enhanced non-specific resistance of mice to influenza virus infection, and to analyse the mechanism. mixture was incubated in a 5 % CO2 incubator at 37 °C for 4 h. After centrifugation, the radioactivity of 0.5 ml of the supernatant fluid was measured. Autologous controls were employed for base-line release values in all experiments. The specific cytotoxicity was calculated by the formula of Hashimoto & Sudo (1971) .
RESULTS

Effect of TDM on influenza virus infection
TDM-10 emulsion-inoculated or control emulsion-inoculated mice and uninoculated mice were infected intranasally with 102 LDs0 in 25 ~tl influenza virus, and subsequent deaths were recorded for 2 weeks. The results presented in Fig. 1 show that the mice inoculated with TDM emulsion at 7 days (data not shown) or 14 days before infection acquired high resistance to influenza virus infection, but not the mice inoculated with TDM-10 emulsion 1 day before infection (data not shown) or with control emulsion 14 days before infection. The enhanced resistance was greatly diminished in TDM-10 emulsion-inoculated mice by treatment prior to infection with ATMA. These results suggest that some function of thymus-dependent lymphocytes provides augmented resistance. Effective doses of TDM were then determined. As shown in Table 1 , the 50% minimum effective dose of TDM was 2.5 ~tg/mouse.
In these experiments, mice were treated with TDM-10 emulsion or control emulsion 14 days before virus infection.
Effect of TDM on function of reticuloendothelial system (RES) in mice
The above results do not preclude the possibility that the enhanced function of the entire RES of TDM emulsion-inoculated mice also contributes to the augmented resistance. Therefore, TDM-10 emulsion-inoculated or control emulsion-inoculated mice were examined for carbon clearance activity. Fig. 2 shows that carbon clearance activity was greatly enhanced in TDM emulsion-inoculated mice, and also in control emulsion-inoculated mice, in which enhanced resistance was not shown. These results indicate that the entire RES function in mice does not correlate with the enhanced resistance to virus infection, as in our earlier report (Sakuma et al., 1983) .
Interferon production in lung and serum of TDM emulsion-inoculated and influenza virus-infected. mice In our previous report (Suenaga et al., 1978) , the production of circulating interferon in BCGtreated mice inoculated with low doses of ectromelia virus was lower than that in untreated mice because of the suppressed growth and slower initial dissemination of virus. When these BCGtreated mice were inoculated with a high dose of virus as an interferon inducer, their interferonproducing ability was amplified (Sakuma et al., 1983) . In the present experiment, TDM emulsion-or control emulsion-treated mice were inoculated intranasally with a high dose (10 s'5 LDs0 in 25 ~tl) of influenza virus, and lung and serum were sampled at 12 and 24 h. As shown in Table 2 , augmented interferon production in lung and serum in TDM emulsion-inoculated mice was observed, and interferon production was eliminated by treatment of these mice with ATMA. TDM emulsion alone did not induce interferon production (data not shown), indicating that the enhanced production of interferon was not caused by a priming effect of TDM emulsion.
Effect of TDM on production of antibody in mice
Production of HI antibody in the TDM emulsion-treated mice and the control emulsiontreated mice 7 days after influenza virus infection (102 LDso, intranasally) was higher than that in untreated mice. No difference, however, was observed between TDM emulsion-treated mice and control emulsion-treated mice ( Table 3 ), indicating that higher antibody production in TDM emulsion-and control emulsion-treated mice than that in untreated mice might be caused by the adjuvant activity of Freund's incomplete adjuvant, and not by the function of TDM. On the other hand, treatment of mice with TDM emulsion did not influence the appearance of antibody-producing cells when mice were immunized with SRBC (Table 4) . Fig. 1 . Effect of pretreatment with TDM emulsion or ATMA on mortality after influenza virus infection. Six mice per group were intravenously inoculated with 10 ktg TDM in 0-2 ml oil-in-water emulsion (TDM-10 emulsion) or control emulsion. These mice were intranasally inoculated with 102 LDso in 25 Ixl influenza virus at 1 or 14 days after TDM treatment. One group of TDM-treated mice were intraperitoneally inoculated with 1 ml ATMA (10200 units/ml) at 1 and 2 days before virus infection. ©, TDM-10 emulsion-treated at 14 days before virus infection; O, TDM-10 emulsiontreated at 14 days plus ATMA-treated at 1 and 2 days before virus infection; I1, control emulsiontreated at 14 days before virus infection; I-q, untreated. Fig. 2 . Effect of pretreatment with TDM emulsion or control emulsion on carbon clearance activity in mice (three mice/group) 14 days later. ©, TDM-10 emulsion-treated; I1, control emulsion-treated; V1, untreated. * Mice (four per group) were inoculated intravenously with 0.6 to 100 ~tg TDM in 0.2 ml oil-in-water emulsion (referred to as TDM-0.6 emulsion or TDM-100 emulsion) or control emulsion.
, Mice were intranasally inoculated with 102 LDso in 25 ~tl influenza virus 14 days after TDM treatment. :~ Number of dead mice at 14 days after virus inoculation/number of mice inoculated. ~" Antibody-producing cells were measured 4 days after immunization. Mean + standard deviation of four mice is shown.
Mechanisms of augmented resistance of TDM-treated mice
These values were statistically not significantly different. 
Natural killer cell activity in TDM-treated mice
It has been reported that natural killer cells may be an inmortant factor in host resistance to virus infection (Santoli et al., 1978 ; Bancroft et al., 1981 ; Shellam et al., 1981 ; Kirchner et al., 1982; Kohl & Harmon, 1983) . We therefore examined whether cytotoxic activity of the natural killer cells was enhanced in mice treated with TDM. Each group of TDM-10 emulsion-, TDM-1 emulsion-and control emulsion-treated mice and untreated mice was divided into two sets (three mice/set). One set of each group was intranasally inoculated with 105.5 LDso of influenza virus, and the other set was uninoculated. After 24 h, spleen cells and sera were prepared from each mouse. The cytotoxicity of natural killer cells in spleen cells and the activity of circulating interferon were then assayed. As shown in Table 5 TDM emulsion-treated mice. An enhanced cytotoxicity was detected in both TDM emulsionand control emulsion-treated mice in response to influenza virus infection, indicating an augmentation of natural killer cell activity by interferon produced in response to virus infection. In this experiment, no significant difference in the level of augmented activity of natural killer cells was observed between TDM emulsion-treated mice and control mice. Mice inoculated with poly(rI)-poly(rC) as a control inducer showed a higher activity of natural killer cells and yielded about 20 to 40 times more circulating interferon than that produced in influenza virus-inoculated mice.
Effect of anti-interferon serum on augmented resistance of TDM emulsion-treated mice
The above results suggest that augmented early interferon production by T-lymphocytes in response to influenza virus infection may play an important role in the enhanced resistance of TDM emulsion-treated mice. If so, then it might be possible to demonstrate experimentally that anti-interferon serum, introduced exogenously, diminishes interferon production in TDMtreated mice and reduces the augmented resistance to influenza virus infection.
The results presented in Fig. 3 show that the enhanced resistance of TDM emulsion-treated mice was markedly reduced by treatment of these mice with anti-interferon-ct/fl serum prior to infection. Finally, interferon production in lung and serum of TDM emulsion-treated and antiinterferon-~/fl serum-treated mice in response to influenza virus infection was examined. No detectable interferon level was observed in lung and serum of TDM plus anti-interferon serumtreated mice (Table 6) .
DISCUSSION
The present results have shown that mice treated with TDM emulsion acquired enhanced resistance to influenza virus infection, and that the augmented resistance may be attributed to the enhanced production of interferon in the early period of influenza virus infection, but not to the whole RES and humoral antibody production in the late period. Tsukui (1977) demonstrated that T-lymphocytes are the main interferon producer in response to influenza virus. Table 2 shows that the enhanced interferon production was greatly diminished by treatment of mice with ATMA, suggesting that T-lymphocytes play a major role in interferon production in response to influenza virus; this is in agreement with the report of Tsukui and our earlier report using ectromelia virus-infected mice (Sakuma et al., 1983) . At this time, it is not clear whether t Mice were intraperitoneally inoculated with 1 ml anti-interferon-~/fl sheep serum (10 s neutralizing units/ml) 4 h before inoculation with influenza virus.
TDM directly activates T-lymphocytes or does so indirectly by means of primary activation of macrophages. Earlier reports (Bekierkunst, 1968; Bekierkunst et al., 1969; Barksdale & Kim, 1977; Yamamoto et al., 1980) have shown that TDM has a granulomagenic activity, and that foci of granuloma consist of one or a few macrophages in the centre and accumulated lymphocytes at the periphery. In the lungs of TDM emulsion-treated mice, granuloma were formed in accord with these reports, and the degree of granuloma formation increased with the dose of inoculated TDM and the level of resistance to influenza virus infection; microscopic observation of lung sections showed that the macrophages phagocytosed oil droplets (unpublished data). These results suggest that the primary target cells of TDM may be macrophages which produce a monokine having chemotactic activity for lymphocytes. The non-specific accumulation of lymphocytes may participate in the augmented resistance of mice and enhanced early interferon production. Gresser and colleagues (1976a, b; Rivi6re et al., 1977) , using anti-interferon serum, also showed an important role of early interferon production in the resistance of mice to virus infection. Our experiments with anti-Thy-1.2 monoclonal antibody and anti-interferon-~/fl serum showed that the interferon produced by T-lymphocytes in TDM-treated mice in response to immunologically non-specific influenza virus was interferon-~ or -fl, or both.
It has been reported that natural killer cells play a role in the defence mechanism against virus infection (Santoli et al., 1978; Bancroft et al., 1981 ; Shellam et al., 1981 ; Kirchner et al., 1982; Kohl & Harmon, 1983) , and that the cytotoxicity of natural killer ceils can be increased by nonspecific stimulation with BCG (Wolfe et al., 1976 (Wolfe et al., , 1977 Tracey, 1979; Potter & Moore, 1980) , Corynebacteriumparvum Ojo et al., 1978) , and poly(rI), poly(rC) or interferon Djeu et al., 1979; Welsh, 1981) . The results presented in Table 5 showed that there is no increase of cytotoxic activity of natural killer cells in TDM emulsion-treated mice. An augmented cytotoxicity, however, was observed in TDM emulsion-treated mice and control mice after virus infection, though there was no significant difference between the augmented cytotoxicity of these mice. The increased interferon from Tlymphocytes in response to influenza virus infection acts to stimulate natural killer cells. Recently, it has been reported that natural killer cells may play an important role in virus infection through their own interferon production (Welsh, 1981) . The augmented early interferon production in lung in response to influenza virus infection and the stimulated activity of natural killer cells may function to restrict the early virus replication and its spread to organs.
Further investigations are required to determine whether macrophages do respond initially to TDM, and accumulate T-lymphocytes and natural killer cells, and also by what means these effects are achieved.
